התחייבויות לטווח ארוך להון עצמי: TransMedics Group Inc (TMDX)

Historical price action for TransMedics Group (TMDX) demonstrates a trend where the indicator stands at 1.56. Sales growth is driving the rapid adoption of unique OCS systems. TransMedics Group (TMDX) is transforming transplantation by maintaining organ viability outside the body. Business stability relies on proprietary aviation resources and high-tech US assembly plants, which optimize complex logistics.

This indicator compares credit obligations with a maturity of over one year against equity, reflecting the degree of financial leverage and the company's dependence on external borrowing. Analyzing the long-term debt-to-equity ratio for TransMedics Group (TMDX) allows for an assessment of whether the scaling of high-margin consumables sales is financed through debt or internal funds, thereby eliminating the risk of share dilution during a price decline.